Mirati’s New CEO Clears Out Execs Ahead Of Key Filing And Readout

Keytruda Combo Data Next Week

 
• By Andrew McConaghie
  
Mirati
The San Diego-based company is set to file adagrasib with the US regulator by the end of 2021. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category